Interrupting Violence from within the Trauma Unit and Well Beyond
The MedStar Community Violence Intervention Program at MedStar Washington Hospital Center is currently in the midst of a randomized, controlled trial and was recently highlighted in Health Affairs. The study tracks participants for 1 year, comparing the groups in terms of violent injury recidivism, predisposition to violence, substance abuse, and life satisfaction. Participants in the study have been seen at MWHC’s Level I trauma unit either days, weeks, or even months earlier.
Researchers from MedStar Health to Develop AI-Powered Tools in Partnership with IBM for Biologic Product Adverse Events
Researchers from MedStar Health are partnering with IBM to develop a program for post-market safety and effectiveness surveillance for biologic adverse events. At MedStar Health, the work will be led by Aaron (Zach) Hettinger, MD, MS, and Kristen E. Miller, DrPH, CPPS, and will leverage the informatics capabilities of the MedStar Health National Center for Human Factors in Healthcare to support patient outcomes through safety surveillance for the Food and Drug Administration.
MedStar Health First to Join Innovative Cerner Network of Health Systems to Conduct Clinical Research
MedStar Health is proud to announce it is a founding member and first health system to join the Cerner Learning Health Network, an innovative platform from Cerner Corporation. The purpose of the Cerner Learning Health Network is to provide health systems and clinical research organizations with resources to more efficiently conduct medical studies that ultimately help advance health care for patients and clinicians.
MedStar Rehabilitation Research and Training Center Awarded Funding
Under the direction of Suzanne Groah, MD, MSPH, the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) recently awarded a 5-year $ 4.375 million grant to establish a Rehabilitation Research and Training Center (RRTC) at MedStar National Rehabilitation Hospital. The RRTC will focus its work on neurogenic lower urinary tract dysfunction, which can affect a range of people with physical disabilities.